Medtech Start-Ups: Protaryx Med., ivWatch, Resistell, MastOR, & more

Posted by Life Science Intelligence on Aug 12, 2020 11:07:41 AM

LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Protaryx Medical raises $5.1M in recent Series A

The company is developing a novel device that optimizes transseptal access to the left atrium during structural heart and catheter ablation procedures. To-date, the company has raised $8.3M. Key strategics in the structural heart devices market include Abbott, Edwards Lifesciences, and Medtronic.

Start a Free Trial to Medtech Start-Up Tracker Today

Read More

Topics: Strategics, Medtech, Medtech Venture Capital

Medtech Start-Ups: Quantib, Circadia Health, Tatch, BioSense, & more

Posted by Life Science Intelligence on Aug 11, 2020 10:40:42 AM

LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Quantib is developing artificial intelligence application for medical imaging analyses

The company currently commercializes two FDA-approved radiology imaging analysis platforms – Quantib ND and Quantib Brain. In June 2020, the company received a grant from the European Innovation Council $2.4M. Strategic competitors in this space include GE Healthcare, Philips, and Siemens

Start a Free Trial to Medtech Start-Up Tracker Today

Read More

Topics: Startup, Medtech, Medtech Venture Capital

Medtech Start-Ups Raising Capital and Innovating

Posted by Life Science Intelligence on Jul 2, 2020 10:28:35 AM

OneProjects is combining imaging and data analytics for the treatment of atrial fibrillation
The privately held company, which originated from Bioinnovate Ireland and Trinity College Dublin, raised $12.3M in a June 2020 Series A round. OneProjects touts its VERAFEYE imaging technology as a connected platform for the treatment of atrial fibrillation and cardiac arrhythmia. Strategic competitors in this space include Medtronic, Philips, and Johnson & Johnson.

Read More

Medtech Start-Ups in Strategic Landscape of Abbott, Boston Scientific

Posted by Life Science Intelligence on Jun 23, 2020 9:33:57 PM

Smiths Medical acquires vascular access and infection prevention startup Access Scientific
Access Scientific manufactured the Powerwand, a family of midline and extended dwell catheters. Prior to its acquisition, Access Scientific had raised approximately $21.4M. The value of the acquisition was undisclosed.

Read More

Medtech Start-Ups: Raising Capital & Gaining Attention from Strategics

Posted by Life Science Intelligence on Jun 19, 2020 8:39:03 AM

LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Read More

Medtech Startups Competing with Elekta, Accuray, Abbott, Dexcom

Posted by Life Science Intelligence on Jun 9, 2020 9:49:53 AM

LSI's Medtech Start-Up Tracker is focused exclusively on covering the privately-held innovators changing the medical device landscape.  

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital

Medtech Startups Competing with Medtronic, J&J, Boston Scientific

Posted by Life Science Intelligence on Jun 8, 2020 5:46:35 PM

VenoStent is developing a novel memory polymer for intravascular devices
The company is seeking to improve venous access in hemodialysis patients with its novel shape memory polymer technology. To-date the company has raised $1.3M. Key strategics in this market include: BD, Merit Medical, and W.L Gore.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital

Global Drug Delivery Markets Up $3.6B in 2020 Driven by Coronavirus

Posted by Life Science Intelligence on Apr 17, 2020 5:13:36 PM

Drug delivery products encompass injection devices, infusion pumps and related administration sets, gravity administration sets, vascular access devices, enteral therapy pumps and sets, and external insulin pumps and sets. Our definition specifically excludes orally administered agents, depot and transdermal drugs, and implantable pain pumps.

Read More

Elective Surgical Procedures Postponed by COVID-19

Posted by Life Science Intelligence on Apr 17, 2020 4:50:27 PM

Leading medtech market research firm Life Science Intelligence (LSI) has been tracking surgical procedure volumes across 37 countries for the last decade. The firm is seeing massive shifts in volumes occurring as a result of the Coronavirus pandemic. As a result, the company has released new forecasts for the US and Big-5 Europe in its new COVID-19 Impact Tracker Platform. The company reports that data from China, Japan, South Korea and several other key countries will also be released in the forthcoming weeks.

Read More

COVID-19 Impacts Procedure Volumes and Medical Devices Markets

Posted by Life Science Intelligence on Apr 8, 2020 6:38:43 PM

Medical Devices & Diagnostics (MD&D) companies know they are being impacted by the current pandemic and are seeking independent research to quantify how much their markets will decline or increase, how long the recovery will take, and what factors will determine that recovery.

Read More

Topics: Startup, Strategics, Medtech, Medtech Venture Capital, Surgical Procedure Volumes, COVID-19, Coronavirus